Case report: Gemcitabine intravesical hyperthermic infusion combined with tislelizumab in muscle invasive bladder urothelium carcinoma

BackgroundMuscle invasive bladder urothelium carcinoma is a common urinary tract tumor. With the deepening of research, more and more treatment methods are applied in clinical practice, extending the life of patients. Among them, the clinical application of chemotherapeutic intravesical hyperthermia...

Full description

Bibliographic Details

Published in:	Frontiers in Oncology
Main Authors:	Zheng Du, Huaqi Yin, Shiming Zhao, Yongkang Ma, Zhenghui Sun, Bingqi Dong, Mingkai Zhu, Chaoshuai Zhu, Jiangshan Peng, Tiejun Yang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-12-01
Subjects:	muscle invasive bladder urothelium carcinoma chemotherapy bladder hyperthermia gemcitabine tislelizumab tumor immunotherapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2022.1062655/full